Surgical Techniques for the Management of Placenta Accreta Spectrum

Abstract

The surgical management of placenta accreta spectrum (PAS) is often challenging. There are a variety of techniques and management options described in the literature ranging from uterine sparing to cesarean hysterectomy. Following the inaugural meeting of the Pan-American Society for Placenta Accreta Spectrum a multidisciplinary group collaborated to describe collective recommendations for the surgical management of PAS. In this manuscript, we outline individual components of the procedure and provide suggested direction at key points of a cesarean hysterectomy in the setting of PAS.

Key Points

• The surgical management of PAS requires careful planning and expertise.

• Multidisciplinary team care for pregnancies complicated by PAS can decrease morbidity and mortality.

• Careful surgical techniques can minimize risk of significant hemorrhage by avoiding pitfalls.

Keywords

placenta accreta spectrum - surgical treatment - cesarean hysterectomy

Publikationsverlauf

Artikel online veröffentlicht:
19. Juni 2023

• References

• 1 Grobman WA, Gersnoviez R, Landon MB. et al; National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol 2007; 110 (06) 1249-1255
• 2 Silver RM, Landon MB, Rouse DJ. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107 (06) 1226-1232
• 3 Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol 2019; 221 (03) 208-218
• 4 Grobman WA, Bailit JL, Rice MM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Frequency of and factors associated with severe maternal morbidity. Obstet Gynecol 2014; 123 (04) 804-810
• 5 Bartels HC, Rogers AC, O'Brien D, McVey R, Walsh J, Brennan DJ. Association of implementing a multidisciplinary team approach in the management of morbidly adherent placenta with maternal morbidity and mortality. Obstet Gynecol 2018; 132 (05) 1167-1176
• 6 Eller AG, Bennett MA, Sharshiner M. et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011; 117 (2 Pt 1): 331-337
• 7 Shamshirsaz AA, Fox KA, Salmanian B. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212 (02) 218.e1-218.e9
• 8 Collins SL, Alemdar B, van Beekhuizen HJ. et al; International Society for Abnormally Invasive Placenta (IS-AIP). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol 2019; 220 (06) 511-526
• 9 Hobson SR, Kingdom JC, Murji A. et al. No. 383-screening, diagnosis, and management of placenta accreta spectrum disorders. J Obstet Gynaecol Can 2019; 41 (07) 1035-1049
• 10 Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009; 116 (05) 648-654
• 11 Belfort MA, Shamshirsaz AA, Fox KA. A technique to positively identify the vaginal fornices during complicated postpartum hysterectomy. Am J Obstet Gynecol 2017; 217 (02) 222.e1-222.e3
• 12 Marcellin L, Delorme P, Bonnet MP. et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol 2018; 219 (02) 193.e1-193.e9
• 13 Al-Khan A, Guirguis G, Zamudio S. et al. Preoperative cystoscopy could determine the severity of placenta accreta spectrum disorders: an observational study. J Obstet Gynaecol Res 2019; 45 (01) 126-132
• 14 Matsubara S, Kuwata T, Usui R. et al. Important surgical measures and techniques at cesarean hysterectomy for placenta previa accreta. Acta Obstet Gynecol Scand 2013; 92 (04) 372-377
• 15 Crocetto F, Esposito R, Saccone G. et al. Use of routine ureteral stents in cesarean hysterectomy for placenta accreta. J Matern Fetal Neonatal Med 2021; 34 (03) 386-389
• 16 Tam Tam KB, Dozier J, Martin Jr JN. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review. J Matern Fetal Neonatal Med 2012; 25 (04) 329-334
• 17 Hoffman MS, Whiteman VE, Bushkk SH, Devoe LD. Extended hysterectomy for selected cases of placenta accreta. J Gynecol Surg 2018; 34: 133-137
• 18 Matsubara S. Caesarean hysterectomy for placenta praevia accreta: filling the bladder technique to identify an appropriate bladder separation site. J Obstet Gynaecol 2013; 33 (02) 163-164
• 19 Szlachta-McGinn A, Mei J, Tabsh K, Afshar Y. Transverse versus vertical skin incision for planned cesarean hysterectomy: does it matter?. BMC Pregnancy Childbirth 2020; 20 (01) 65
• 20 Belfort MA, Shamshiraz AA, Fox K. Minimizing blood loss at cesarean-hysterectomy for placenta previa percreta. Am J Obstet Gynecol 2017; 216 (01) 78.e1-78.e2
• 21 Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol 2020; 222 (02) 179.e1-179.e9
• 22 Einerson BD, Branch DW. Surgical management of placenta accreta spectrum. Clin Obstet Gynecol 2018; 61 (04) 774-782
• 23 Shrivastava V, Nageotte M, Major C, Haydon M, Wing D. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol 2007; 197 (04) 402.e1-402.e5
• 24 Salim R, Chulski A, Romano S, Garmi G, Rudin M, Shalev E. Precesarean prophylactic balloon catheters for suspected placenta accreta a randomized controlled trial. Obstet Gynecol 2015; 126 (05) 1022-1028
• 25 Shahin Y, Pang CL. Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis. Eur Radiol 2018; 28 (07) 2713-2726
• 26 Shrivastava VK, Nageotte MP. The utilization of interventional radiologic procedures in the surgical management of placenta accreta syndrome. Clin Obstet Gynecol 2018; 61 (04) 795-807
• 27 Wu Q, Liu Z, Zhao X. et al. Outcome of pregnancies after balloon occlusion of the infrarenal abdominal aorta during caesarean in 230 patients with placenta praevia accreta. Cardiovasc Intervent Radiol 2016; 39 (11) 1573-1579
• 28 Wei Y, Luo J, Luo D. Comparison of efficacy between internal iliac artery and abdominal aorta balloon occlusions in pernicious placenta previa patients with placenta accrete. Gynecol Obstet Invest 2019; 84 (04) 343-349
• 29 Wang M, Ballah D, Wade A. et al. Uterine artery embolization following cesarean delivery but prior to hysterectomy in the management of patients with invasive placenta. J Vasc Interv Radiol 2019; 30 (05) 687-691
• 30 Sivan E, Spira M, Achiron R. et al. Prophylactic pelvic artery catheterization and embolization in women with placenta accreta: can it prevent cesarean hysterectomy?. Am J Perinatol 2010; 27 (06) 455-461
• 31 Liu J, Wang Y, Jiao D, Zhang W, Han X. Prophylactic occlusion balloon placement in the abdominal aorta combined with uterine or ovarian artery embolization for the prevention of cesarean hysterectomy due to placenta accreta: a retrospective study. Cardiovasc Intervent Radiol 2019; 42 (06) 829-834
• 32 Nicholson PJ, O'Connor O, Buckley J, Spence LD, Greene RA, Tuite DJ. Prophylactic placement of internal iliac balloons in patients with abnormal placental implantation: maternal and foetal outcomes. Cardiovasc Intervent Radiol 2018; 41 (10) 1488-1493
• 33 Picel AC, Wolford B, Cochran RL, Ramos GA, Roberts AC. Prophylactic internal iliac artery occlusion balloon placement to reduce operative blood loss in patients with invasive placenta. J Vasc Interv Radiol 2018; 29 (02) 219-224
• 34 Nelson G, Bakkum-Gamez J, Kalogera E. et al. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer 2019; 29 (04) 651-668
• 35 Wilson RD, Caughey AB, Wood SL. et al. Guidelines for antenatal and preoperative care in cesarean delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1). Am J Obstet Gynecol 2018; 219 (06) 523.e1-523.e15
• 36 Welz J, Keyver-Paik MD, Gembruch U, Merz WM. Self-reported physical, mental, and reproductive sequelae after treatment of abnormally invasive placenta: a single-center observational study. Arch Gynecol Obstet 2019; 300 (01) 95-101
• 37 Erfani H, Fox KA, Clark SL. et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol 2019; 221 (04) 337.e1-337.e5
• 38 Silver RM, Fox KA, Barton JR. et al. Center of excellence for placenta accreta. Am J Obstet Gynecol 2015; 212 (05) 561-568
• 39 Shamshirsaz AA, Fox KA, Erfani H. et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol 2017; 216 (06) 612.e1-612.e5